Rajen Dalal, president and CEO of Guava Technologies, has joined Ciphergen Biosystems’ board of directors. Bill Green, president and CEO of Stanford Research Systems, has resigned from the board of the company.
Following the acquisition of Semaia Pharmaceuticals by Hybrigenics (see p.1), Rian de Jonge, former CEO of Utrecht, the Netherlands-based Semaia, has become executive VP for research and development at Paris-based Hybrigenics.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
